Georgia Deliyannis

Melbourne, VIC 3000, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Historic 1994 influenza vaccine cohorts define breadth of antibody and B cell responses toward future influenza A and B viruses.

Historic 1994 influenza vaccine cohorts define breadth of antibody and B cell responses toward future influenza A and B viruses.

Journal: Science translational medicine
Published: April 01, 2026

Bovine tracheal organoids for studying Mycoplasma bovis respiratory infections.

Bovine tracheal organoids for studying Mycoplasma bovis respiratory infections.

Journal: Veterinary microbiology
Published: August 16, 2024

mRNA vaccines encoding membrane-anchored RBDs of SARS-CoV-2 mutants induce strong humoral responses and can overcome immune imprinting.

mRNA vaccines encoding membrane-anchored RBDs of SARS-CoV-2 mutants induce strong humoral responses and can overcome immune imprinting.

Journal: Molecular therapy. Methods & clinical development
Published: October 30, 2023

Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster.

Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster.

Journal: EBioMedicine
Published: July 17, 2023

Uncovering strain- and age-dependent innate immune responses to SARS-CoV-2 infection in air-liquid-interface cultured nasal epithelia.

Uncovering strain- and age-dependent innate immune responses to SARS-CoV-2 infection in air-liquid-interface cultured nasal epithelia.

Journal: iScience
Published: May 19, 2023

Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccine.

Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccine.

Journal: EBioMedicine
Published: September 15, 2022

Nonhuman primate models for evaluation of SARS-CoV-2 vaccines.

Nonhuman primate models for evaluation of SARS-CoV-2 vaccines.

Journal: Expert review of vaccines
Published: June 02, 2022

Air-Liquid-Interface Differentiated Human Nose Epithelium: A Robust Primary Tissue Culture Model of SARS-CoV-2 Infection.

Air-Liquid-Interface Differentiated Human Nose Epithelium: A Robust Primary Tissue Culture Model of SARS-CoV-2 Infection.

Journal: International journal of molecular sciences
Published: December 22, 2021

TLR2-mediated activation of innate responses in the upper airways confers antiviral protection of the lungs.

TLR2-mediated activation of innate responses in the upper airways confers antiviral protection of the lungs.

Journal: JCI insight
Published: May 14, 2020

Discovery of a novel iflavirus sequence in the eastern paralysis tick Ixodes holocyclus.

Discovery of a novel iflavirus sequence in the eastern paralysis tick Ixodes holocyclus.

Journal: Archives of virology
Published: November 30, 2017

Salivary Blockade Protects the Lower Respiratory Tract of Mice from Lethal Influenza Virus Infection.

Salivary Blockade Protects the Lower Respiratory Tract of Mice from Lethal Influenza Virus Infection.

Journal: Journal of virology
Published: April 12, 2017

The design and proof of concept for a CD8(+) T cell-based vaccine inducing cross-subtype protection against influenza A virus.

The design and proof of concept for a CD8(+) T cell-based vaccine inducing cross-subtype protection against influenza A virus.

Journal: Immunology and cell biology
Published: November 14, 2012
Showing 1-12 of 13

Last Updated: 09/26/2026